Epidemiologic aspects of human T-lymphotropic virus type I (HTLV-I) infection have been
thoroughly studied over the course of approximately 25 years since its first description. The …

VER A DECADE HAS passed since ''Immunologic Classification of Leukemia and
Lymphoma''by Foon and Todd was published in Blood. 1 Over this decade, flow Acute …

Human T-cell lymphotropic virus type I (HTLV-I) is the first human retrovirus to be associated
with malignant disease—namely, adult T-cell leukaemia/lymphoma. HTLV-I has also been …

Adult T-cell leukemia-lymphoma (ATL) is an intractable mature T-cell neoplasm. We
performed a nationwide retrospective study of allogeneic hematopoietic stem cell …

Adult T-cell leukaemia/lymphoma (ATLL) is a mature T-cell neoplasm of post-thymic
lymphocytes aetiologically linked to the human T-cell lymphotropic virus, HTLV-I, and with a …

In recent years, the increasing number of donors from different regions of the world is
providing a new challenge for the management and selection of suitable donors. This is a …

Human T lymphotropic virus type 1 (HTLV-1) is one of the most intriguing retroviruses
infecting humans. Most commonly, infection remains undetected, since it does not cause …

HTLV-I is the first retrovirus to be associated directly with human malignancy. In ATL-
endemic areas, the rate of HTLV-I carriers is high. Both HTLV-I and ATL have been shown to …

Background Human T-lymphotropic virus 1 (HTLV-1) infection has an especially high
prevalence in Japan. Transmission has been confirmed in infancy through breastfeeding; …

This study provides an overview of the epidemiology and secular trends of malignant
lymphoma in Japan. Using data from clinics and hospitals throughout Japan, we analyzed …